R2G2: NIH New Simplified Review Framework

NIH has simplified its peer review process for most research project grants! The new framework for NIH Peer Review Criteria reorganized Significance, Investigators, Innovation, Approach, and Environment into three factors, all of which contribute to the overall impact score. Reviewers are now asked to evaluate proposals based on three central questions: How important is the proposed research, how rigorous and feasible are the methods, and whether the investigators and institution have the expertise/resources necessary to carry out the project.

If you’d like to learn more about the framework from the reviewer’s perspective, register today! You’ll hear from Stanford faculty who recently served on various study sections that used the new framework!

About the Presenters:

Vinicio de Jesus Perez, MD is an Associate Professor of Medicine and a staff physician at the Stanford Adult Pulmonary Hypertension Clinic. He devotes his clinical practice to diagnosing and managing genetic and molecular mechanisms of pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF). Dr. Jesus Perez trains fellows pursuing careers in PH and IPF and is the principal investigator of a research program to identify new therapeutic targets for treating PH and IPF. He serves on the Pulmonary Vascular Disease and Physiology study section.

David Maahs, MD PhD is the Lucile Salter Packard Professor of Pediatrics, Division Chief of Pediatric Endocrinology, and Associate Chair for Academic Affairs in Pediatrics at Stanford and the Lucile Packard Children’s Hospital. His scholarly interest is improving care and preventing complications in people with type 1 diabetes (T1D). Dr. Maahs has conducted epidemiologic studies that help generate hypotheses for clinical studies, including trials to develop artificial pancreas systems to improve glucose control, lower disease burden, prevent the complications of diabetes, and reduce disparities in diabetes care. He serves on the Human Studies of Diabetes and Obesity study section.

Victoria Parikh, MD is an Associate Professor Medicine in Cardiovascular Medicine at Stanford and Director of the Stanford Center for Inherited Cardiovascular Disease. Dr. Parikh’s own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. She recently served on the Integrative Myocardial Physiology/Pathophysiology B study section.

In the meantime, learn more about the new framework here: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review/framework

Route to Getting Grants (R2G2) is specially designed for early-career faculty at Stanford. Sessions cover all aspects of grant writing, delivered through panel sessions, workshops and focused talks. R2G2 also provides unique networking opportunities, enabling cross faculty collaborations and multidisciplinary partnerships. R2G2 ensures that early-career faculty have all the tools and strategies to lead them to grant success and on to independent research careers.